Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 464 across all filing types
Latest filing 2019-08-29 Board/Management Inform…
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the outcome of a Board Meeting held on August 29, 2019. It lists decisions made by the Board, including setting the venue, date, and time for the 4th Annual General Meeting, approval of the AGM notice and Directors Report for FY 2018-19, appointment of a Scrutinizer for the AGM, and approval of a preferential allotment of shares subject to shareholder approval. The document is an announcement of Board Meeting outcomes and decisions, not the actual Directors Report or AGM notice themselves. It is not a full financial report or earnings release, nor is it a voting result or proxy solicitation. The key content is about Board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is short (1597 characters), consistent with a meeting outcome announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2019-08-29 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a short notice informing about the rescheduling of a Board Meeting, addressed to stock exchanges. It mentions the date and time of the meeting and that the agenda remains unchanged. There is no financial data, no detailed report, no voting results, no management discussion, or any other substantive content. The document is only an announcement of a meeting date change, which fits the category of Board/Management Information (MANG). The document length is short (1312 characters), and it is clearly not a report or detailed filing. Therefore, the classification is MANG with high confidence.
2019-08-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges reporting the outcome of a board meeting held on August 12, 2019. It mentions the approval and recording of unaudited financial results for the quarter ended June 30, 2019, along with a limited review report. It also mentions the withdrawal of a proposed rights issue. The document is short (1969 characters) and primarily serves as an announcement of the board meeting outcome and financial results, not the full financial report itself. It references the unaudited financial results and limited review report being attached but does not contain detailed financial statements or substantive financial data. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about financial results and corporate actions, not the full interim report or earnings release itself.
2019-08-21 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the postponement of a scheduled Board of Directors meeting. It references a previous announcement and states that the meeting will be rescheduled and announced later. There is no financial data, no report attached or published, and no detailed discussion of financial results or governance changes. This is an announcement related to board meeting scheduling, which falls under Board/Management Information (MANG). The document length is short and it is clearly an announcement, not a report or transcript.
2019-08-17 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for August 19, 2019. The agenda includes deciding the date and venue of the 4th Annual General Meeting (AGM), approving the Directors Report for the financial year 2018-19, approving the draft Notice of the AGM, appointing a scrutinizer for e-voting at the AGM, and considering the issue of equity shares on a preferential basis. The document is an announcement of a Board Meeting and does not contain any financial data, detailed reports, or results. It is primarily an intimation of a board meeting and agenda items, which fits the category of Board/Management Information (MANG). The document length is short (1869 characters), and it is not a report itself but a notice of a meeting where reports will be approved. Therefore, the correct classification is MANG with high confidence.
2019-08-13 English
Financial Result Updates
Regulatory Filings
2019-08-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.